Meet the team reimagining protein biomarker quantitation
Paul is a serial entrepreneur with a track record of successful commercialization and exits. His companies – CellASIC and Combinati – were acquired by Millipore Sigma and Thermo Fisher Scientific, respectively. At Taudia, Paul draws on his extensive experience to turn cutting-edge science into market-ready products.
Cindy is a seasoned biochemist and certified project management professional. With deep R&D experience across startups and large companies – including Millipore Sigma – she now brings her technical expertise and operational leadership to drive strategic execution at Taudia. Her mission to improve health care through technology pushed her to co-found Taudia.
Robert brings over a decade of product development expertise in both the IVD and RUO spaces. He led next-gen platform development at Cepheid and microfluidics innovation at Combinati before joining Thermo Fisher Scientific as a Senior Product Manager. His drive to improve lives through science and technology inspired him to co-found Taudia.
Hien is an expert in immunoassay chemistry with over 15 years of experience in protein detection assay development. At Thermo Fisher Scientific, he was instrumental in designing and optimizing high-performance assays across different platforms. As the inventor of Taudia’s founding innovations, Hien now leads the company’s technical development with relentless scientific rigor.
Jason has a passion for translating ideas into impactful products. He earned his PhD in Biomedical Engineering from Georgia Tech, where he developed microfluidic tools to study aging. After launching his first products at Thermo Fisher Scientific, Jason co-founded Taudia to build more accessible tools for neuroscience.
Noah brings multidisciplinary expertise in assay development, automation, and computational analysis built over eight years at Thermo Fisher Scientific. He played a key role in launching multiple products, making his broad experience a perfect match for Taudia’s mission to deliver scalable, accessible solutions.
Paul is a serial entrepreneur with a track record of successful commercialization and exits. His companies – CellASIC and Combinati – were acquired by Millipore Sigma and Thermo Fisher Scientific, respectively. At Taudia, Paul draws on his extensive experience to turn cutting-edge science into market-ready products.
Cindy is a seasoned biochemist and certified project management professional. With deep R&D experience across startups and large companies – including Millipore Sigma – she now brings her technical expertise and operational leadership to drive strategic execution at Taudia. Her mission to improve health care through technology pushed her to co-found Taudia.
Robert brings over a decade of product development expertise in both the IVD and RUO spaces. He led next-gen platform development at Cepheid and microfluidics innovation at Combinati before joining Thermo Fisher Scientific as a Senior Product Manager. His drive to improve lives through science and technology inspired him to co-found Taudia.
Hien is an expert in immunoassay chemistry with over 15 years of experience in protein detection assay development. At Thermo Fisher Scientific, he was instrumental in designing and optimizing high-performance assays across different platforms. As the inventor of Taudia’s founding innovations, Hien now leads the company’s technical development with relentless scientific rigor.
Jason has a passion for translating ideas into impactful products. He earned his PhD in Biomedical Engineering from Georgia Tech, where he developed microfluidic tools to study aging. After launching his first products at Thermo Fisher Scientific, Jason co-founded Taudia to build more accessible tools for neuroscience.
Noah brings multidisciplinary expertise in assay development, automation, and computational analysis built over eight years at Thermo Fisher Scientific. He played a key role in launching multiple products, making his broad experience a perfect match for Taudia’s mission to deliver scalable, accessible solutions.
Kyan Younes, MD
Clinical
Neurologist, Stanford University School of Medicine
Edward (Ted) Wilson, PhD
Scientific
Director of Biofluid Biomarker testing, Stanford's Alzheimer’s Disease Research Center
Charles (Chuck) Collins, PhD
IVD Instrumentation
Former Head of R&D & SVP at Luminex
Wendy Wong
IVD Strategy
Former VP of PMO at Cepheid
Sander Gubbens, PhD
Business
Former President of Gatan
Dr. Norm Gitis
Business
Former VP/GM of Bruker
Dr. Ralph McDade
Business
Former President of RBM (an IQVIA company)
Jennifer Yokoyama, PhD
Scientific
Associate Professor, Neurology Mary Oakley Foundation Professor in Neurodegeneration UCSF Weill Institute for Neurosciences
Dr. Kyan Younes
Clinical
Neurologist, Stanford Medical
Dr. Ted Wilson
Scientific
Director of biofluid biomarker testing at Stanford Alzheimer’s Disease Research Center (ADRC)
Dr. Chuck Collins
IVD Instrumentation
Former Head of R&D & SVP at Luminex, COMBiNATi BOD
Wendy Wong
IVD Strategy
Former VP of PMO at Cepheid
Dr. Sander Gubbens
Business
Former President of Gatan, COMBiNATi BOD
Dr. Norm Gitis
Business
Former VP/GM of Bruker
Dr. Ralph McDade
Business
Former President of RBM (an IQVIA company)
Jennifer Yokoyama, PhD
Scientific
Associate Professor, Neurology Mary Oakley Foundation Professor in Neurodegeneration UCSF Weill Institute for Neurosciences